Discovery of novel 17-phenylethylaminegeldanamycin derivatives as potent Hsp90 inhibitors.
about
17-ABAG, a novel geldanamycin derivative, inhibits LNCaP-cell proliferation through heat shock protein 90 inhibition.The HSP90 inhibitor 17-PAG effectively inhibits the proliferation and migration of androgen-independent prostate cancer cellsNatural Product Inspired N-Terminal Hsp90 Inhibitors: From Bench to Bedside?
P2860
Discovery of novel 17-phenylethylaminegeldanamycin derivatives as potent Hsp90 inhibitors.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Discovery of novel 17-phenylet ...... es as potent Hsp90 inhibitors.
@en
type
label
Discovery of novel 17-phenylet ...... es as potent Hsp90 inhibitors.
@en
prefLabel
Discovery of novel 17-phenylet ...... es as potent Hsp90 inhibitors.
@en
P2093
P2860
P356
P1476
Discovery of novel 17-phenylet ...... es as potent Hsp90 inhibitors.
@en
P2093
Chunhua Lu
Guowei Shi
Lejiao Jia
Xingkang Wu
Yuemao Shen
P2860
P304
P356
10.1111/CBDD.12371
P577
2014-06-26T00:00:00Z